TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Mias Lymfterapi AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
85
|
104
|
119 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-23
|
42
|
47 |
| EBITDA |
-27
|
41
|
47 |
| Total assets |
248
|
281
|
235 |
| Current assets |
248
|
281
|
235 |
| Current liabilities |
12
|
27
|
29 |
| Equity capital |
235
|
253
|
205 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.8%
|
90.0%
|
87.2% |
| Turnover per employee |
85
|
104
|
119 |
| Profit as a percentage of turnover |
-27.1%
|
40.4%
|
39.5% |
| Return on assets (ROA) |
-9.3%
|
14.9%
|
20.0% |
| Current ratio |
2066.7%
|
1040.7%
|
810.3% |
| Return on equity (ROE) |
-9.8%
|
16.6%
|
22.9% |
| Change turnover |
-22
|
-23
|
41 |
| Change turnover % |
-20%
|
-18%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.